Skip to main content
OpenTrials
Completed

NCT Number: NCT04351542

Ayurveda for Flu Like Illness During Covid-19 Outbreak

This study aimed to evaluate the efficacy and safety of Ayurveda in reducing symptoms of flu like illness during the Covid 19 outbreak.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Flu Like Illness

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Aarogyam

Leicester, United Kingdom

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with fu like symptoms within 48 hours of onset during March2020
  • Mild to moderate symptoms who were advised to self isolate at home for 7-14 days
  • Flu like symptoms present at least one respiratory symptom (e.g. cough, nasal obstruction, sore throat) and at least one constitutional symptom other than fever (e.g. fatigue, headache, myalgias) of less than 48-hour duration
  • Willing to consent and follow up

Exclusion criteria

  • Pregnant/lactating
  • Participants with chronic pulmonary diseases or critical condition or already developed severe respiratory distress
  • Clinically malignancies, systemic infection, other medical or psychiatric condition which places the subject at unacceptable risk to participate in the study - Known hypersensitivity to any ayurveda herbal substances
  • Severe symptoms of respiratory distress patients deemed to require intensive care immediately

Treatment and study plan

Ayurveda

Dietary Supplement

Based on individual constitution (ayurveda based assessment) and symptoms an individual has, ayurveda herbal supplement and self managed practices were advised along with usual care recommendation.

Usual Care

Other

Usual care recommended by National Health Services, self isolation, plenty fluid, rest and Paracetamol. During the Covid 19 outbreak, additional recommendation were followed given by health services.

Primary outcomes

  1. Time to achieve afebrile

    Time frame: Change from baseline to 3rd and 7th-day

    Time to bring down a fever (oral temperature < 37.2 ̊C)

  2. Severity of symptom score

    Time frame: Change from baseline to 3rd and 7th day

    Symptoms diary card completed twice daily from Day 0 to Day 7

Secondary outcomes

  1. Patient reported improvement

    Time frame: Change from baseline to 3rd and 7th-day

    Patient reported improvement using 4 scale; 0-none, 1-weak, 2-medium, 3-strong

Sponsors and collaborators

Lead sponsor

Aarogyam UK

Other

Registry information

Official study title

Ayurveda for Flu-like Illness During the Covid 19 Outbreak: Non Randomised Single-blind Controlled Trial

Important dates

Study start
2020
Primary completion
2020
Study completion
2020
First posted
Apr 17, 2020
Registry last updated
Apr 17, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.